Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Cisplatin and Potassium

supplement:

Potassium

Research Papers that Mention the Interaction

Our study identified two compounds, namely potassium antimony tartrate and topotecan, that significantly enhanced the sensitivity of colorectal and non-small cell lung cancer cells to CDDP.
International journal of oncology  •  2018  |  View Paper
The potassium currents were enhanced to 192< by the application of cisplatin (0.5 mM).
Journal of cancer research and therapeutics  •  2016  |  View Paper
Cisplatin caused a significant decrease in glomerular filtration rate (GFR), urine osmolarity, and urinary excretion rate of potassium , but significant increase in the kidney index and histological damage compared with the control group.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia  •  2018  |  View Paper
Results showed that cisplatin injection caused significant decreases in the serum sodium (Na+), potassium (K+), bicarbonate (HCO3-), calcium (Ca2+), phosphate (PO42-) and concomitant significant increases in the serum urea and creatinine levels.
Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria  •  2016  |  View Paper
PurposeAdministration of cisplatin causes changes in magnesium and potassium metabolism.
Cancer Chemotherapy and Pharmacology  •  2004  |  View Paper
Decreased urinary levels of glucose, sodium and potassium reflected a protective action against the renal dysfunction caused by cisplatin.
Renal failure  •  2000  |  View Paper
There was a significant rise in potassium (K+), sodium (Na+), and chlorine (Cl−) in the endolymph of the animals treated with CDDP as compared with the control animals.
The Annals of otology, rhinology, and laryngology  •  1995  |  View Paper
Tubular fluid sodium, chloride, and potassium concentrations were lower at the papillary tip in cis-platinum treated rats (p less than 0.01).
Canadian journal of physiology and pharmacology  •  1987  |  View Paper
Cisplatin , an effective anti-tumor agent, has significant effects on renal function including reduced glomerular filtration rate and potassium and magnesium wasting.
Kidney international  •  1985  |  View Paper
Intracellular effects of cisplatin cause tubular damage and tubular dysfunction with sodium, potassium , and magnesium wasting.
Journal of nephropharmacology  •  2014  |  View Paper